ICON Public Limited Company
HealthcareNASDAQ:ICLR · NASDAQ Global Select
-$4.14 today
Vol 0.70M · Avg 1.16M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$8.2B of revenue converted into $488.7M of net income for the selected period. Gross margin is 25.2% and net margin is 6.0%, showing how much revenue survives after costs and taxes. EPS is $6.16, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3B -0.4% | $8.3B +2.0% | $8.1B +4.9% | $7.7B +41.2% | $5.5B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $6.1B +3.9% | $5.8B +2.2% | $5.7B +3.5% | $5.5B +39.1% | $4.0B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $2.2B -10.7% | $2.4B +1.5% | $2.4B +8.4% | $2.2B +46.8% | $1.5B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 26.4% -3.1pp | 29.4% -0.1pp | 29.6% +1.0pp | 28.6% +1.1pp | 27.5% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $780.1M +7.1% | $728.3M -6.2% | $776.4M -0.3% | $778.8M +33.0% | $585.3M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.2B -13.1% | $1.3B -7.3% | $1.4B +1.8% | $1.4B +25.6% | $1.1B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $383.0M -21.6% | $488.5M -16.6% | $586.0M -4.7% | $614.7M +70.6% | $360.3M | $374.2M | $1.2B | $631.8M |
| EBITDA | $823.6M -47.3% | $1.6B +2.8% | $1.5B +7.7% | $1.4B +91.0% | $739.4M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 10.0% -8.9pp | 18.9% +0.1pp | 18.7% +0.5pp | 18.2% +4.8pp | 13.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | $1.0B -7.8% | $1.1B +14.8% | $956.2M +20.2% | $795.2M +110.1% | $378.5M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 12.3% -1.0pp | 13.3% +1.5pp | 11.8% +1.5pp | 10.3% +3.4pp | 6.9% | 16.6% | 24.1% | 22.0% |
| Interest Income | $7.1M -17.4% | $8.6M +71.7% | $5.0M +113.8% | $2.3M +308.5% | $574.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $188.1M -20.7% | $237.2M -29.5% | $336.7M +46.6% | $229.7M +25.9% | $182.4M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$760.0M -232.4% | -$228.6M +31.1% | -$331.7M -43.9% | -$230.5M -25.3% | -$184.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $252.5M -71.0% | $869.2M +39.3% | $624.1M +10.5% | $564.7M +190.3% | $194.5M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 3.1% -7.4pp | 10.5% +2.8pp | 7.7% +0.4pp | 7.3% +3.7pp | 3.5% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $23.1M -70.2% | $77.7M +561.4% | $11.7M -80.2% | $59.4M +43.7% | $41.3M | $1.3B | -$1.6B | $745.2M |
| Net Income | $229.3M -71.0% | $791.5M +29.3% | $612.3M +21.2% | $505.3M +229.9% | $153.2M | $4.9B | $4.8B | $4.7B |
| Net Margin | 2.8% -6.8pp | 9.6% +2.0pp | 7.5% +1.0pp | 6.5% +3.7pp | 2.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $3 -69.6% | $10 +28.7% | $7 +20.3% | $6 +171.9% | $2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $3 -69.6% | $10 +28.8% | $7 +20.7% | $6 +172.4% | $2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $78.4M -4.9% | $82.5M +0.5% | $82.1M +0.7% | $81.5M +21.5% | $67.1M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $79.0M -4.9% | $83.0M +0.4% | $82.7M +0.3% | $82.5M +21.2% | $68.1M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Exact Sciences Corporation
EXAS
$20.03B
Guardant Health, Inc.
NASDAQ:GH
$17.31B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$16.15B
Solventum Corporation
NYSE:SOLV
$13.54B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.40B
The Cooper Companies, Inc.
NASDAQ:COO
$13.22B
Revvity, Inc.
NYSE:RVTY
$11.11B
Encompass Health Corporation
NYSE:EHC
$10.11B
Universal Health Services, Inc.
NYSE:UHS
$9.18B
Qiagen N.V.
NYSE:QGEN
$7.65B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ICLR generate?
ICON Public Limited Company (ICLR) reported $8.25B of revenue in fiscal 2025.
Is ICLR profitable?
ICON Public Limited Company (ICLR) reported $229.34M of net income, with a net margin of 2.8%.
Explore More
Continue the stock analysis
Jump to another research area for this company.